At Hiba Pharma, we are committed to excellence in oncology pharmaceutical manufacturing. Through cutting-edge technology, rigorous quality standards, and innovative research, we develop life-saving cancer treatments that improve patient outcomes.
With a focus on precision, compliance, and accessibility, we strive to set new benchmarks in oncology care. Our mission is clear: to advance pharmaceutical quality and enrich lives by providing safe, effective, and reliable therapies for those who need them most.
Launched UAE-based operations with a strategic focus on oncology manufacturing.
Established business office at Dubai Science Park.
Licensing & Tech transfer agreements with Kelix Bio and Novugen Pharma.
Ground breaking in KEZAD, Abu Dhabi.
Licensing & Tech Transfer agreement with SAKAR Healthcare.
Civil and structural work.
MEP and commissioning.
Facility inauguration and EDE cGMP approval.
Tech transfer Phase.
GMP inspections GCC, SFDA.
MEP and commissioning.
HIBA Pharma takes pride in operating state-of-the-art manufacturing facility in in Kezad, Abu Dhabi, UAE, equipped with the latest industry technologies.
Our facility is being built to comply with cGMP regulations and international standards, ensuring the highest safety, efficacy, and quality standards in every product we manufacture.
We are proud to be the only local facility producing sterile injectable oncology medications. We stand at the forefront of pharmaceutical advancements, reinforcing our commitment to addressing unmet medical needs.
HIBA Pharma is dedicated to provide high-quality pharmaceutical solutions that address critical healthcare challenges. Our diverse product portfolio spans multiple therapeutic categories that include but not limited to:
HIBA PHARMA actively seeks partnerships with forward-thinking pharmaceutical firms that share our commitment to innovation, quality, and patient-centric approach through Licensing, Technology Transfer and Contract Manufacturing.
Hiba Pharma, has taken a significant step towards realizing its vision of becoming a regional leader in specialty pharmaceuticals. The company has inaugurated its new office in Dubai Science Park, a move that is expected to play a key role in the implementation of its strategic plans.
Hiba Pharma, has taken a significant step towards realizing its vision of becoming a regional leader in specialty pharmaceuticals. The company has inaugurated its new office in Dubai Science Park, a move that is expected to play a key role in the implementation of its strategic plans.
Hiba Pharma, has taken a significant step towards realizing its vision of becoming a regional leader in specialty pharmaceuticals. The company has inaugurated its new office in Dubai Science Park, a move that is expected to play a key role in the implementation of its strategic plans.
Hiba Pharma, has taken a significant step towards realizing its vision of becoming a regional leader in specialty pharmaceuticals. The company has inaugurated its new office in Dubai Science Park, a move that is expected to play a key role in the implementation of its strategic plans.
Launched UAE-based operations with a strategic focus on oncology manufacturing. Established business office at Dubai Science Park.
Licensing & Tech transfer agreements with Kelix Bio and Novugen Pharma. Ground breaking in KEZAD, Abu Dhabi.
Licensing & Tech Transfer agreement with SAKAR Healthcare. Civil and structural work.
MEP and commissioning.
Facility inauguration and EDE cGMP approval. Tech transfer Phase. GMP inspections GCC, SFDA.
HIBA Pharma is driven by a passion to enhance the quality of life of people worldwide. We strive to be the leading provider of top-quality specialty pharmaceutical products.
